CDK4 and neoplasm: In this regard, and to further support our hypothesis that radiolabeled Cdk4 inhibitors are suitable radiotracers for tumor imaging, comprehensive in vivo experiments of [124I]CKIA and [124I]CKIB involving biodistribution and small animal PET studies [37] should be performed.